Literature DB >> 18206427

Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.

Jia-Rong Fan1, An-Lin Peng, Hsiang-Chin Chen, Shu-Chi Lo, Ting-Hsiang Huang, Tsai-Kun Li.   

Abstract

Cytotoxic action (tumor cell killing) and carcinogenic side effect (therapy-related secondary leukemia) of etoposide are closely related to its ability in stabilizing topoisomerase II cleavable complex (TOP2cc), a unique form of protein-linked DNA break. How cells process and detect TOP2-concealed DNA damage for the activation of downstream cellular responses remains unclear. Here, we showed proteasomal degradation of both TOP2 isozymes in a transcription-dependent manner upon etoposide treatment. Downregulation of TOP2 was preferentially associated with proteasomal removal of TOP2 in TOP2cc rather than proteolysis of free TOP2. Interestingly, blockage of TOP2 downregulation in TOP2cc also caused reduction in etoposide-induced activation of DNA damage molecules, an observation suggesting that the processing pathways of TOP2cc are involved in activation of etoposide-induced cellular responses. In this regard, we observed two TOP2cc processing pathways, replication- and transcription-initiated processing (RIP and TIP) with proteasome involved in the latter. Importantly, two processing pathways contributed to differential activation of various DNA damage signaling and downstream cellular responses. Etoposide-induced phosphorylation of p53 relied mainly on RIP, whereas activation of Chk1, Chk2 depended largely on TIP. Both RIP and TIP played roles in activating non-homologous end joining pathway, while only RIP modulated etoposide-induced cell killing in a p53-dependent manner. Collectively, our results are consistent with the notion that protein-linked DNA breakage (e.g., TOP2cc) requires processing pathways for initiating downstream DNA damage detection, repair as well as cell death programs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206427     DOI: 10.1016/j.dnarep.2007.12.002

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  20 in total

Review 1.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 2.  Recognition and repair of chemically heterogeneous structures at DNA ends.

Authors:  Sara N Andres; Matthew J Schellenberg; Bret D Wallace; Percy Tumbale; R Scott Williams
Journal:  Environ Mol Mutagen       Date:  2014-08-11       Impact factor: 3.216

3.  A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.

Authors:  Rebecca L Swan; Ian G Cowell; Caroline A Austin
Journal:  Mol Pharmacol       Date:  2021-05-03       Impact factor: 4.436

4.  Calcium-induced cleavage of DNA topoisomerase I involves the cytoplasmic-nuclear shuttling of calpain 2.

Authors:  Shang-Min Chou; Ting-Hsiang Huang; Hsiang-Chin Chen; Tsai-Kun Li
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

5.  Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathway.

Authors:  Jui-Ling Hsu; Yunn-Fang Ho; Tsai-Kun Li; Ching-Shih Chen; Lih-Ching Hsu; Jih-Hwa Guh
Journal:  Biochem Pharmacol       Date:  2012-04-02       Impact factor: 5.858

Review 6.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

7.  Topoisomerase IIalpha-dependent induction of a persistent DNA damage response in response to transient etoposide exposure.

Authors:  Sébastien Soubeyrand; Louise Pope; Robert J G Haché
Journal:  Mol Oncol       Date:  2009-10-09       Impact factor: 6.603

8.  Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination.

Authors:  Marcelo de Campos-Nebel; Irene Larripa; Marcela González-Cid
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

9.  Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2.

Authors:  Matthew J Schellenberg; C Denise Appel; Sanjay Adhikari; Patrick D Robertson; Dale A Ramsden; R Scott Williams
Journal:  Nat Struct Mol Biol       Date:  2012-10-28       Impact factor: 15.369

10.  MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA.

Authors:  Ka Cheong Lee; Kay Padget; Hannah Curtis; Ian G Cowell; Davide Moiani; Zbyslaw Sondka; Nicholas J Morris; Graham H Jackson; Simon J Cockell; John A Tainer; Caroline A Austin
Journal:  Biol Open       Date:  2012-07-11       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.